Skinvisible, Inc. (SKVI)

$0.1301

0.00 (0.00%)
Rating:
Recommendation:
-
Symbol SKVI
Price $0.1301
Beta -0.423
Volume Avg. 0.00M
Market Cap 0.591M
Shares () -
52 Week Range 0.101-0.3687
1y Target Est -
DCF Unlevered SKVI DCF ->
DCF Levered SKVI LDCF ->
ROE 11.00% Buy
ROA -190.20% Strong Sell
Operating Margin -
Debt / Equity -105.51% Sell
P/E -
P/B -0.10 Neutral
Annual
Quarter

Earnings

Consensus EPS

Upgrades & Downgrades


Mr. Terry H. Howlett
Consumer Defensive
Household & Personal Products
Other OTC

Skinvisible, Inc., together with its subsidiaries, focuses on the development, manufacture, and sale of topical, transdermal, and mucosal polymer-based delivery system technologies and formulations for use in pharmaceutical, over the counter, personal skincare, and cosmetic arenas. Its non-dermatological formulations offer solutions for women's health, pain management, and other markets. The company offers sunless tanning and sunscreen products under the Skinbrella name. It also licenses to pharmaceutical and consumer goods companies; assists pharmaceutical clients in the early development of the formulations; and provides solutions to pharmaceutical companies by reformulating their products coming off patent with a new Invisicare patent, and new product benefits and line extensions. The company was formerly known as Microbial Solutions, Inc. and changed its name to Skinvisible, Inc. in February 1999. Skinvisible, Inc. was incorporated in 1998 and is based in Las Vegas, Nevada.